Jean Adams v. Merck Sharp & Dohme Corp., et al

15-56997

December 07, 2017
9th Circ. Vacates Drug Liability MDL Ruling Favoring Merck

A Ninth Circuit panel on Wednesday vacated a win for Merck Sharp & Dohme Corp. and other drugmakers in a suit claiming that they failed to warn consumers about pancreas problems from Type 2 diabetes drugs, sending the class action back to the district court that the panel said erroneously interpreted a U.S. Supreme Court ruling.
September 07, 2016
Patients Seek Revival Of Diabetes Drug Claims In 9th Circ.

Consumers on Wednesday pushed the Ninth Circuit to revive state-law claims that Merck and other drugmakers failed to warn them of pancreas problems from Type 2 diabetes drugs, saying that a lower court's erroneous interpretation of a U.S. Supreme Court ruling sent the entire multidistrict litigation off-track.
July 25, 2016
Merck Urges 9th Circ. To Reject Diabetes Drug Warning Claims

Merck and other drugmakers have urged the Ninth Circuit to uphold the toss of state-law claims that the companies failed to warn patients of pancreas problems from Type 2 diabetes drugs, saying the U.S. Food and Drug Administration would have rejected such warnings.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:

Law360